Across TCGA pan-cancer cohorts, OR7E5P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OR7E5P data layer compared with 15 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher OR7E5P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E5P expression acts as an unfavorable survival marker.

OV, LUAD, and SKCM are the cancer types where OR7E5P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	II,III,IV	0.289	0.692	.020	18	view →
LUAD	OS	Median	III,IV	0.068	0.680	<.001	14	view →
SKCM	DFS	Median	All	0.433	0.732	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: OR7E5P tumor-vs-normal RNA expression · all OR7E5P data types